FormWeb • inotuzumab ozogamicin

Ochsner Health

Ochsner Health System Formulary

Formulary Addition Request Questions or Suggestions?

Search by class Show Therapeutic Classes

SDS Online Do Not Crush OHS Pharmacy Contact Louisiana Poison Control
(800) 222-1222

Webpage Links

Add Formweb to your mobile device

Android iOS

Ochsner Health COVID-19 SharePoint Site "Safety On Site" Click here to enter an S.O.S.

Medications listed are available on OH EPIC Formulary, unless otherwise noted.
Not all formulary medications are available at each facility. Please refer to your local pharmacy for available inventory.

Ochsner Health

Ochsner Health System Formulary

Formulary Addition Request Questions or Suggestions?

HIGH ALERT: Please review policy carefully.

Search results for:

inotuzumab ozogamicin

inotuzumab ozogamicin

Drug Name	Form	Strength	Infusion Center Available	Restricted	Non-formulary	Ambulatory Available	Interchange	REMS
Besponsa	POWDER FOR INJECTION, INTRAVENOUS	0.9 mg

VIEW MORE Antineoplastic Agents
CLASS

High Alert Drug : Policy

Additional Information and Links

RESTRICTED:
Besponsa is Restricted to Oncology Outpatients Only.

Last updated: Oct. 18, 2022

inotuzumab ozogamicin

Black Box Warning: Hepatotoxicity, Increased Risk of Post-Hematopoietic Stem Cell, Transplant Non-Relapse Mortality
HazD: PPE, Disposal, and Assessment of Risk
HazD: Group 1: Antineoplastic

This site is intended for the staff of Ochsner Health. While others may view accessible pages, Ochsner Health makes no warranty, express or implied, as to the use of this information outside of Ochsner Health.